Literature DB >> 27190045

Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Hannah P Yang, Kelsey R Murphy, Ruth M Pfeiffer, Neena George, Montserrat Garcia-Closas, Jolanta Lissowska, Louise A Brinton, Nicolas Wentzensen.   

Abstract

Previous studies have shown that a greater number of ovulatory cycles, cumulatively summed as lifetime number of ovulatory cycles (LOC), increases ovarian cancer risk, but there is no uniform algorithm with which to compute LOC. The association between LOC and endometrial cancer is less certain. Accordingly, we identified 14 different LOC algorithms in a literature review and calculated LOCs in the Polish Cancer Study (2001-2003). We evaluated the associations of LOC with ovarian and endometrial cancer risks using unconditional logistic regression, with and without adjustment for individual risk factors used in the LOC computations. Our analysis included 302 ovarian cancer cases with 1,356 controls and 532 endometrial cancer cases with 1,286 controls. We found a high correlation between LOC values among the combined controls (r ≥ 0.88) and identified 5 groups of similar LOC algorithms. A LOC value in the highest quartile was associated with ovarian cancer risk as computed by 2 algorithms (odds ratio (OR) = 2.22 (95% confidence interval (CI): 1.07, 4.62) and OR = 2.44 (95% CI: 1.22, 4.87)) and with endometrial cancer risk as computed by 1 algorithm (OR = 1.95, 95% CI: 1.11, 3.44). LOC algorithms using a core set of variables widely available in epidemiologic studies may be independently associated with risk of gynecological cancers beyond the contribution of the individual risk factors, such as ages at menopause and menarche. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  age at menarche; age at menopause; endometrial cancer; incessant ovulation; lifetime ovulatory cycles; ovarian cancer; ovulation

Mesh:

Year:  2016        PMID: 27190045      PMCID: PMC4851993          DOI: 10.1093/aje/kwv308

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  32 in total

1.  Predicting age at menopause.

Authors:  D W Cramer; H Xu
Journal:  Maturitas       Date:  1996-04       Impact factor: 4.342

Review 2.  Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses.

Authors:  Jean S Fleming; Clare R Beaugié; Izhak Haviv; Georgia Chenevix-Trench; Olivia L Tan
Journal:  Mol Cell Endocrinol       Date:  2005-11-16       Impact factor: 4.102

Review 3.  The epidemiology of endometrial and ovarian cancer.

Authors:  Daniel W Cramer
Journal:  Hematol Oncol Clin North Am       Date:  2011-11-25       Impact factor: 3.722

4.  Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.

Authors:  Claudio Pelucchi; Carlotta Galeone; Renato Talamini; Cristina Bosetti; Maurizio Montella; Eva Negri; Silvia Franceschi; Carlo La Vecchia
Journal:  Am J Obstet Gynecol       Date:  2007-01       Impact factor: 8.661

Review 5.  The normal menstrual cycle in women.

Authors:  M Mihm; S Gangooly; S Muttukrishna
Journal:  Anim Reprod Sci       Date:  2010-09-03       Impact factor: 2.145

6.  Menstrual bleeding patterns among regularly menstruating women.

Authors:  Sonya S Dasharathy; Sunni L Mumford; Anna Z Pollack; Neil J Perkins; Donald R Mattison; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2012-02-20       Impact factor: 4.897

7.  Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup.

Authors:  Joellen M Schildkraut; Patricia G Moorman; Amy E Bland; Susan Halabi; Brian Calingaert; Regina Whitaker; Paula S Lee; Tyler Elkins-Williams; Rex C Bentley; Jeffrey R Marks; Andrew Berchuck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

8.  Menstruation span--a time-limited risk factor for endometrial carcinoma.

Authors:  B Pettersson; H O Adami; R Bergström; E D Johansson
Journal:  Acta Obstet Gynecol Scand       Date:  1986       Impact factor: 3.636

9.  Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.

Authors:  Ko-Hui Tung; Marc T Goodman; Anna H Wu; Katharine McDuffie; Lynne R Wilkens; Laurence N Kolonel; Abraham M Y Nomura; Keith Y Terada; Michael E Carney; Leslie H Sobin
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

10.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group.

Authors:  A S Whittemore; R Harris; J Itnyre
Journal:  Am J Epidemiol       Date:  1992-11-15       Impact factor: 4.897

View more
  18 in total

1.  Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations.

Authors:  Britton Trabert; Tim Waterboer; Annika Idahl; Nicole Brenner; Louise A Brinton; Julia Butt; Sally B Coburn; Patricia Hartge; Katrin Hufnagel; Federica Inturrisi; Jolanta Lissowska; Alexander Mentzer; Beata Peplonska; Mark E Sherman; Gillian S Wills; Sarah C Woodhall; Michael Pawlita; Nicolas Wentzensen
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

2.  Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.

Authors:  Holly R Harris; Ana Babic; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Francesmary Modugno; Roberta B Ness; Kirsten B Moysich; Susanne K Kjær; Estrid Høgdall; Allan Jensen; Joellen M Schildkraut; Andrew Berchuck; Daniel W Cramer; Elisa V Bandera; Nicolas Wentzensen; Joanne Kotsopoulos; Steven A Narod; Catherine M Phelan; John R McLaughlin; Hoda Anton-Culver; Argyrios Ziogas; Celeste L Pearce; Anna H Wu; Kathryn L Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

3.  Estimated Number of Lifetime Ovulatory Years and Its Determinants in Relation to Levels of Circulating Inflammatory Biomarkers.

Authors:  Tianyi Huang; Amy L Shafrir; A Heather Eliassen; Kathryn M Rexrode; Shelley S Tworoger
Journal:  Am J Epidemiol       Date:  2020-07-01       Impact factor: 4.897

4.  Huang et al. Respond to "Ovulation and Systemic and Localized Inflammation Markers" and "Capturing Women's Reproductive Life Spans".

Authors:  Tianyi Huang; Amy L Shafrir; A Heather Eliassen; Kathryn M Rexrode; Shelley S Tworoger
Journal:  Am J Epidemiol       Date:  2020-07-01       Impact factor: 4.897

5.  Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.

Authors:  Sarah R Irvin; Elisabete Weiderpass; Frank Z Stanczyk; Louise A Brinton; Britton Trabert; Hilde Langseth; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-01-13       Impact factor: 4.254

6.  Reproductive factors and incidence of endometrial cancer in U.S. black women.

Authors:  Todd R Sponholtz; Julie R Palmer; Lynn Rosenberg; Elizabeth E Hatch; Lucile L Adams-Campbell; Lauren A Wise
Journal:  Cancer Causes Control       Date:  2017-03-30       Impact factor: 2.506

7.  Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.

Authors:  Lauren C Peres; Patricia G Moorman; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul D Terry; Sarah E Abbott; Fabian Camacho; Frances Wang; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2017-03-02       Impact factor: 2.506

8.  Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.

Authors:  Francesmary Modugno; Zhuxuan Fu; Susan J Jordan; Aocs Group; Jenny Chang-Claude; Renée T Fortner; Marc T Goodman; Kirsten B Moysich; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Bo Qin; Rebecca Sutphen; John R McLaughlin; Usha Menon; Susan J Ramus; Simon A Gayther; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Celeste L Pearce; Anna H Wu; Harvey A Risch; Penelope M Webb
Journal:  Eur J Epidemiol       Date:  2020-09-21       Impact factor: 8.082

9.  Cancer Progress and Priorities: Uterine Cancer.

Authors:  Ashley S Felix; Louise A Brinton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09       Impact factor: 4.254

10.  The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).

Authors:  Britton Trabert; Shelley S Tworoger; Katie M O'Brien; Mary K Townsend; Renée T Fortner; Edwin S Iversen; Patricia Hartge; Emily White; Pilar Amiano; Alan A Arslan; Leslie Bernstein; Louise A Brinton; Julie E Buring; Laure Dossus; Gary E Fraser; Mia M Gaudet; Graham G Giles; Inger T Gram; Holly R Harris; Judith Hoffman Bolton; Annika Idahl; Michael E Jones; Rudolf Kaaks; Victoria A Kirsh; Synnove F Knutsen; Marina Kvaskoff; James V Lacey; I-Min Lee; Roger L Milne; N Charlotte Onland-Moret; Kim Overvad; Alpa V Patel; Ulrike Peters; Jenny N Poynter; Elio Riboli; Kim Robien; Thomas E Rohan; Dale P Sandler; Catherine Schairer; Leo J Schouten; Veronica W Setiawan; Anthony J Swerdlow; Ruth C Travis; Antonia Trichopoulou; Piet A van den Brandt; Kala Visvanathan; Lynne R Wilkens; Alicja Wolk; Anne Zeleniuch-Jacquotte; Nicolas Wentzensen
Journal:  Cancer Res       Date:  2020-01-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.